Skip to main content
OpenTrials
Completed

NCT Number: NCT02080936

Does Muscle Wasting Always Mean Muscle Weakness? A Prevalence Study in COPD

Peripheral muscle mass and strength are relevant indicators of COPD survival. Current guidelines recommend to assess muscle strength only in muscle wasted patients. However, a recent study reported quadriceps weakness without muscle wasting (Menon, M et al. Resp. Res.2012, 13:119). Thus, these guidelines raise the risk to miss out some weak patients. In clinical settings, fat-free-mass index (FFMI) is indicated as a simple index to assess muscle wasting. We aimed at determining the prevalence of patients entering in pulmonary rehabilitation (PR) a priori not eligible for muscle strength evaluation given the lack of muscle wasting clinical signs.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Clinique du Souffle La Vallonie

Lodève, 34700, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who have got FFMI (bioimpedance)
  • Patients who have done quadriceps muscle strenght evaluation

Exclusion criteria

  • Patients without FFMI
  • Patients without quadriceps muscle strenght

Treatment and study plan

Primary outcomes

  1. Muscle wasting in COPD patient

    Time frame: baseline

Secondary outcomes

  1. Muscle weakness in COPD patient

    Time frame: baseline

Sponsors and collaborators

Lead sponsor

5 Santé

Other

Registry information

Acronym: M2W

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Mar 7, 2014
Registry last updated
Mar 7, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.